Sciety

Analysis of SARS-CoV-2 Antibodies in COVID-19 Convalescent Blood using a Coronavirus Antigen Microarray

This article has 27 authors:
1. Rafael R. de Assis
2. Aarti Jain
3. Rie Nakajima
4. Algis Jasinskas
5. Jiin Felgner
6. Joshua M. Obiero
7. Oluwasanmi Adenaiye
8. Sheldon Tai
9. Filbert Hong
10. Philip J. Norris
11. Mars Stone
12. Graham Simmons
13. Anil Bagri
14. Martin Schreiber
15. Andreas Buser
16. Andreas Holbro
17. Manuel Battegay
18. Philip Hosimer
19. Charles Noesen
20. Donald K. Milton
21. Prometheus Study Group
22. D. Huw Davies
23. Paul Contestable
24. Laurence M. Corash
25. Michael P. Busch
26. Philip L. Felgner
27. Saahir Khan
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Apr 17, 2020Latest activity Jun 5, 2020
Genome based evolutionary lineage of SARS-CoV-2 towards the development of novel chimeric vaccine

This article has 9 authors:
1. Mst Rubaiat Nazneen Akhand
2. Kazi Faizul Azim
3. Syeda Farjana Hoque
4. Mahmuda Akther Moli
5. Bijit Das Joy
6. Hafsa Akter
7. Ibrahim Khalil Afif
8. Nadim Ahmed
9. Mahmudul Hasan
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Nov 1, 2020Latest activity Jun 5, 2020
Comparative in vitro transcriptomic analyses of COVID-19 candidate therapy hydroxychloroquine suggest limited immunomodulatory evidence of SARS-CoV-2 host response genes

This article has 5 authors:
1. Michael J. Corley
2. Christopher Sugai
3. Michael Schotsaert
4. Robert E. Schwartz
5. Lishomwa C. Ndhlovu
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Apr 14, 2020Latest activity Jun 5, 2020
De novo design and Rosetta‐based assessment of high‐affinity antibody variable regions (Fv) against the SARS‐CoV ‐2 spike receptor binding domain ( RBD )

This article has 7 authors:
1. Veda Sheersh Boorla
2. Ratul Chowdhury
3. Ranjani Ramasubramanian
4. Brandon Ameglio
5. Rahel Frick
6. Jeffrey J. Gray
7. Costas D. Maranas
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Oct 8, 2022Latest activity Jun 5, 2020
Classical drug digitoxin inhibits influenza cytokine storm, with implications for COVID-19 therapy

This article has 4 authors:
1. Bette S. Pollard
2. Jorge C. Blanco
3. John R. Pollard
4. Gregory A. Prince
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Apr 11, 2020Latest activity Jun 5, 2020
Currently available intravenous immunoglobulin (Gamunex ^® -C and Flebogamma ^® DIF) contains antibodies reacting against SARS-CoV-2 antigens

This article has 3 authors:
1. José-María Díez
2. Carolina Romero
3. Rodrigo Gajardo
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Apr 10, 2020Latest activity Jun 5, 2020
Analysis of the SARS-CoV-2 spike protein glycan shield: implications for immune recognition

This article has 4 authors:
1. Oliver C. Grant
2. David Montgomery
3. Keigo Ito
4. Robert J. Woods
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Apr 9, 2020Latest activity Jun 5, 2020
JAK1 Inhibition Blocks Lethal Immune Hypersensitivity in a Mouse Model of Down Syndrome

This article has 16 authors:
1. Kathryn D. Tuttle
2. Katherine A. Waugh
3. Paula Araya
4. Ross Minter
5. David J. Orlicky
6. Michael Ludwig
7. Zdenek Andrysik
8. Matthew A. Burchill
9. Beth A.J. Tamburini
10. Colin Sempeck
11. Keith Smith
12. Ross Granrath
13. Dayna Tracy
14. Jessica Baxter
15. Joaquin M. Espinosa
16. Kelly D. Sullivan
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Nov 1, 2020Latest activity Jun 5, 2020
Gene expression and in situ protein profiling of candidate SARS-CoV-2 receptors in human airway epithelial cells and lung tissue

This article has 22 authors:
1. Jennifer A. Aguiar
2. Benjamin J-M. Tremblay
3. Michael J. Mansfield
4. Owen Woody
5. Briallen Lobb
6. Arinjay Banerjee
7. Abiram Chandiramohan
8. Nicholas Tiessen
9. Anna Dvorkin-Gheva
10. Spencer Revill
11. Matthew S. Miller
12. Christopher Carlsten
13. Louise Organ
14. Chitra Joseph
15. Alison John
16. Paul Hanson
17. Bruce M. McManus
18. Gisli Jenkins
19. Karen Mossman
20. Kjetil Ask
21. Andrew C. Doxey
22. Jeremy A. Hirota
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Apr 9, 2020Latest activity Jun 5, 2020
Energetics based epitope screening in SARS CoV-2 (COVID 19) spike glycoprotein by Immuno-informatic analysis aiming to a suitable vaccine development

This article has 3 authors:
1. Amrita Banerjee
2. Dipannita Santra
3. Smarajit Maiti
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Apr 5, 2020Latest activity Jun 5, 2020

Previous Page 42 of 173 Next

Immunology

Analysis of SARS-CoV-2 Antibodies in COVID-19 Convalescent Blood using a Coronavirus Antigen Microarray

Genome based evolutionary lineage of SARS-CoV-2 towards the development of novel chimeric vaccine

Comparative in vitro transcriptomic analyses of COVID-19 candidate therapy hydroxychloroquine suggest limited immunomodulatory evidence of SARS-CoV-2 host response genes

De novo design and Rosetta‐based assessment of high‐affinity antibody variable regions (Fv) against the SARS‐CoV ‐2 spike receptor binding domain ( RBD )

Classical drug digitoxin inhibits influenza cytokine storm, with implications for COVID-19 therapy

Currently available intravenous immunoglobulin (Gamunex ^® -C and Flebogamma ^® DIF) contains antibodies reacting against SARS-CoV-2 antigens

Analysis of the SARS-CoV-2 spike protein glycan shield: implications for immune recognition

JAK1 Inhibition Blocks Lethal Immune Hypersensitivity in a Mouse Model of Down Syndrome

Gene expression and in situ protein profiling of candidate SARS-CoV-2 receptors in human airway epithelial cells and lung tissue

Energetics based epitope screening in SARS CoV-2 (COVID 19) spike glycoprotein by Immuno-informatic analysis aiming to a suitable vaccine development